Abstract:Objective To fabricate an ultrasound/fluorescence bi-modal contrast agent by encapsulating fluorescent quantum dots into polymeric ultrasound contrast agent microbubbles.Methods Polylactic acid (PLA,500 mg),(1R)-(+)-camphor (50 mg) and CdSe/ZnS quantum dots (0.5 ml,2.3 μmol/L)were dissolved or dispersed in dichloromethane (10 ml) to form in an organic phase.Ammonium carbonate solution and poly (vinyl alcohol) solution were employed as the internal and external water phase,respectively.The fluorescent microbubbles were generated using double emulsion solvent evaporation and lyophilization methods.The morphology and illumination were characterized by scanning electron microscopy (SEM) and fluorescence spectrophotometry.Synchronized contrast-enhanced ultrasound and fluorescence imaging was acquired by injecting fluorescent microbubbles into the silicone tube coupled to a self-made ultrasound/fluorescence imaging device.Ultrasound/fluorescence bi-modal in vivo imaging was acquired on the kidney of New Zealand rabbits and suckling mice.Results The fluorescent microbubbles were hollow spheres with an averaged diameter of (1.62 ± 1.47) μm.More than 99％ of these microbubbles were less than 8 μm in diameter,which meeted the size criteria for ultrasound contrast agents.The fluorescence emission peak of the microbubbles appeared at 632 nm,indicating that good luminescence properties of quantum dots were maintained.In vitro ultrasound/fluorescence imaging showed no echoic signal when the silicone tube was filled with saline,but there was a strong echo when filled with fluorescent microbubbles.The liquid column with fluorescent microbubbles emitted red luminescence under ultraviolet irradiation.The kidney of the rabbit was remarkably enhanced after the administration of fluorescent microbubbles.Bright fluorescence could be observed at the injection site of the suckling mice via subcutaneous injection.Conclusions A bi-modal but single contrast agent based on polymeric microbubbles has been successfully fabricated for the use of ultrasound and fluorescence imaging.It retains the good characteristics of both echogenicity and fluorescence,which complement each other in case of limitations imposed by uni-modal,single agents.

Polymeric antibubbles with strong ultrasound imaging capabilities

Polymeric materials for ultrasound imaging and therapy

Polymeric Microbubble Shell Engineering: Microporosity as a Key Factor to Enhance Ultrasound Imaging and Drug Delivery Performance

Antibubbles enable tunable payload release with low-intensity ultrasound

Oscillating endoskeletal antibubbles

Microbubbles Stabilized by Protein Shell: From Pioneering Ultrasound Contrast Agents to Advanced Theranostic Systems

Advances in antibubble formation and potential applications

Novel Microbubbles for Ultrasonic Imaging Based on Surfactants

Development of a Polymer Ultrasound Contrast Agent Incorporating Nested Carbon Nanodots

Triple-Emulsion-Based Antibubbles: A Step Forward in Fabricating Novel Multi-Drug Delivery Systems

Bubble-In-Bubble Strategy for High-Quality Ultrasound Imaging with A Structure Coupling Effect

Novel ultrasound contrast agent based on microbubbles generated from surfactant mixtures of Span 60 and polyoxyethylene 40 stearate.

Targeted Soft Biodegradable Glycine/Peg/Rgd-Modified Poly(Methacrylic Acid) Nanobubbles As Intelligent Theranostic Vehicles for Drug Delivery

Spatially Selective Acoustic Pressure Reporting Using Antibubbles

Freeze-Dried Microfluidic Monodisperse Microbubbles as a New Generation of Ultrasound Contrast Agents

Fabrication and Imaging Study of Ultrasound/fluorescence Bi-Modal Contrast Agent Based on Polymeric Microbubbles

Air-Filled Microbubbles Based on Albumin Functionalized with Gold Nanocages and Zinc Phthalocyanine for Multimodal Imaging

Fluorinated Copolypeptide‐Stabilized Microbubbles with Maleimide‐Decorated Surfaces As Long‐Term Ultrasound Contrast Agents

Ultrabubble: A Laminated Ultrasound Contrast Agent with Narrow Size Range

Truly Tiny Acoustic Biomolecules for Ultrasound Imaging and Therapy

Sonic shrinking of Pickering-stabilised ultrasound contrast agent at a low acoustic amplitude